TC
CORT icon

TwinBeech Capital’s Corcept Therapeutics CORT Stock Holding History

TwinBeech Capital’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-31,392
Closed -$698K – 674
2023
Q2 		$698K Buy
+31,392
New +$723K 0.01% 482
2023
Q1 		– Sell
-20,277
Closed -$412K – 660
2022
Q4 		$412K Buy
+20,277
New +$508K 0.01% 610
2021
Q2 		– Sell
-12,250
Closed -$291K – 467
2021
Q1 		$291K Sell
12,250
-11,839
-49% -$316K 0.04% 382
2020
Q4 		$630K Buy
+24,089
New +$508K 0.1% 249

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return